Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database-Reference-Cited by-同舟云学术

Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database

Published:2012-09-19 Issue:4 Volume:73 Page:409-417
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Abern Michael R.,Aronson William J.,Terris Martha K.,Kane Christopher J.,Presti Joseph C.,Amling Christopher L.,Freedland Stephen J.

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.22582/fullpdf

Reference31 articles.

1. The implementation of screening for prostate cancer;van Leeuwen;Prostate Cancer Prostatic Dis,2010

2. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience;Tosoian;J Clin Oncol,2011

3. Prostate cancer death of men treated with initial active surveillance: Clinical and biochemical characteristics;Krakowsky;J Urol,2010

4. A multi-institutional evaluation of active surveillance for low risk prostate cancer;Eggener;J Urol,2009

5. Contemporary evaluation of the D'Amico risk classification of prostate cancer;Hernandez;Urology,2007

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act;Cancer Medicine;2023-08-03

2. Time from biopsy to radical prostatectomy by race in an equal‐access healthcare system: Results from the SEARCH cohort;The Prostate;2023-04-25

3. Role of Race and Insurance Status in Prostate Cancer Diagnosis-to-Treatment Interval;Clinical Genitourinary Cancer;2022-12

4. Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy;World Journal of Urology;2022-11-11

5. Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative;European Urology Open Science;2022-07